生命科学工具、研究服务和临床解决方案提供商CellBio收购BioChain，以加强其在细胞模型和临床前研究领域的领导地位-动脉网

CellBio Scientific Acquires BioChain to Strengthen Leadership in Cellular Models and Preclinical Research

CISION 等信源发布 2025-05-01 22:00



可切换为仅中文







NEWARK, Calif.

加利福尼亚州纽瓦克

，

May 1, 2025

2025年5月1日

/PRNewswire/ -- CellBio Scientific, a premier provider of life science tools, research services, and clinical solutions, today announced the acquisition of BioChain, a leading provider of biospecimen collection, preparation, and analysis.

/PRNewswire/ -- 生命科学工具、研究服务和临床解决方案的领先提供商CellBio Scientific今天宣布收购生物样本收集、制备和分析的领先供应商BioChain。

The acquisition strengthens CellBio Scientific's platform at a pivotal moment in drug discovery and development, as the industry focuses on using human-relevant research models and analyses. The combined platform will be well-positioned to meet growing demand for innovative tools and translational research solutions..

此次收购增强了 CellBio Scientific 在药物发现和开发关键时刻的平台实力，因为该行业正专注于使用与人类相关的研究模型和分析。合并后的平台将能够很好地满足对创新工具和转化研究解决方案不断增长的需求。

'BioChain has built a strong reputation over decades by delivering reliable, high-quality solutions to the global scientific and medical communities,' said

“BioChain在过去的几十年里，通过向全球科学和医学界提供可靠、高质量的解决方案，建立了良好的声誉，”表示

Charles Miller

查尔斯·米勒

, CEO of CellBio Scientific. 'This acquisition is highly complementary to our existing capabilities at System Biosciences and Acepix Biosciences. Together, we are building a unified platform that empowers discovery through scientific excellence, operational depth, and customer focus.'

CellBio Scientific首席执行官表示：“此次收购对System Biosciences和Acepix Biosciences的现有能力高度互补。我们正在共同打造一个统一的平台，通过科学卓越、运营深度和以客户为中心来推动发现。”

BioChain is widely recognized for its expertise in biological sample collection, preparation, and analysis, with a strong foundation in spatial genomics and biospecimen workflows. Its biospecimens are fully consented under IRB approval and products are routinely used by CLIA-certified laboratories, diagnostic test manufacturers, and translational research teams seeking high-quality, regulatory-compliant inputs..

BioChain因其在生物样本采集、制备和分析方面的专业知识而广受认可，并在空间基因组学和生物样本工作流程方面拥有坚实的基础。其生物样本均在IRB批准下获得充分知情同意，产品常规被CLIA认证实验室、诊断测试制造商以及寻求高质量、合规输入的转化研究团队使用。

'Joining CellBio Scientific allows BioChain to accelerate its impact while continuing to do what we do best—support life sciences innovation with trusted biospecimen and discovery solutions,' said

“加入CellBio Scientific使BioChain能够加快其影响力，同时继续专注于我们最擅长的事情——通过值得信赖的生物样本和发现解决方案支持生命科学创新，”

Grace Tian

田格雷斯

, CEO of BioChain. 'This brings new opportunities to serve our customers and collaborate across a broader platform.'

BioChain首席执行官表示：“这为我们服务客户和在更广泛的平台上开展合作带来了新的机遇。”

BioChain's headquarters and operations will remain in

BioChain的总部和运营将保留在

Newark, California

纽瓦克，加利福尼亚州

. The company's leadership team will continue to guide local operations, with the BioChain CEO now reporting directly to Miller.

公司领导团队将继续指导当地业务，生物链首席执行官现在直接向米勒汇报工作。

This marks CellBio Scientific's third strategic integration since its formation, following the consolidation of System Biosciences (SBI) and Acepix Biosciences in 2024. Together, the platform is uniquely positioned to support the next generation of drug discovery and biomedical innovation.

这标志着CellBio Scientific自成立以来的第三次战略整合，继2024年System Biosciences（SBI）和Acepix Biosciences合并之后。该平台共同处于独特的位置，能够支持下一代药物发现和生物医学创新。

About CellBio Scientific:

关于CellBio科学：

CellBio Scientific is a premier provider of life science tools, research services, and clinical solutions advancing the frontiers of biomedical discovery. Formed through the strategic integration of System Biosciences (SBI), Acepix Biosciences and BioChain, the company offers a comprehensive portfolio spanning biospecimens, spatial biology, extracellular vesicle technologies, gene delivery systems, cell-based models, and preclinical and clinical histopathology services.

CellBio Scientific 是一家领先的生命科学工具、研究服务和临床解决方案供应商，致力于推动生物医学发现的前沿。公司通过战略性整合 System Biosciences (SBI)、Acepix Biosciences 和 BioChain 而成，提供涵盖生物样本、空间生物学、细胞外囊泡技术、基因递送系统、基于细胞的模型以及临床前和临床组织病理学服务的全面产品组合。

With a deep commitment to scientific excellence and innovation, CellBio Scientific empowers researchers, biopharma partners, and clinicians to drive breakthroughs in human health..

秉承对科学卓越和创新的深厚承诺，CellBio Scientific 赋予研究人员、生物制药合作伙伴和临床医生推动人类健康突破的能力。

For more information, contact Matthew Lorence at

如需更多信息，请联系马修·洛伦斯

mclorence@cellbioscientific.com

。

Contact Information:

联系信息：

CellBio Scientific

细胞生物科学

Matthew C. Lorence

马修·C·洛伦斯

925-765-8205